Related by context. Frequent words. (Click for all words.) 73 primary percutaneous coronary 67 patients undergoing percutaneous 61 #mg/day [001] 61 undergoing coronary artery 61 Arch Intern Med 60 coronary intervention 60 mg QD 60 XIENCE V demonstrated 59 paclitaxel eluting stents 59 coronary revascularization 58 confidence interval #.#-#.# 58 cerebrovascular events 58 Randomized controlled 58 repeat revascularization 58 N Engl J 58 Percutaneous Coronary Intervention 58 tirofiban 58 TAXUS p value 58 beta blocker therapy 58 XIENCE V vs. 57 coronary interventions 57 normotensive 57 TAXUS Stent 57 Secondary endpoints included 57 lipid lowering drugs 56 endarterectomy 56 Am J Cardiol 56 left ventricular systolic 56 RRMS patients 56 LMWH 56 CI #.#-#.# [002] 56 primary hypercholesterolemia 56 prespecified 56 lispro 56 % CI #.#-#.# [003] 56 clopidogrel Plavix 56 nonobese 56 NYHA Class II 56 neoadjuvant 56 thromboembolic 56 annualized relapse 56 Secondary endpoints include 56 carotid artery stenting 56 Thrombolysis 56 Patients Undergoing 56 HIV uninfected 56 acute coronary syndromes ACS 56 p = .# [002] 55 percutaneous coronary interventions 55 poor metabolizers 55 unfractionated heparin 55 revascularisation 55 stable angina 55 acute ischemic stroke 55 myocardial infarction MI 55 thrombolytic therapy 55 % CI #.#-#.# [007] 55 cardiac resynchronization 55 acute myocardial infarction AMI 55 Taxus Stent 55 FOLFOX4 55 #:#-# [031] 55 plus prednisone 55 prospective observational 55 plus dexamethasone 55 advanced adenomas 55 relapsing multiple sclerosis 55 adenotonsillectomy 55 retrospectively reviewed 54 left ventricular dysfunction 54 coronary artery bypass grafting 54 coronary stenting 54 Acute Myocardial Infarction 54 irbesartan 54 % CI #.#-#.# [006] 54 randomized multicenter 54 target lesion revascularization 54 lipid lowering therapy 54 lanthanum carbonate 54 virologic failure 54 CABG surgery 54 statistically significant p = 54 IABP 54 aspirin beta blockers 54 P = .# 54 nonfatal myocardial infarction 54 sirolimus eluting stent 54 PREZISTA r 54 nonrandomized 54 lamotrigine 54 thromboembolic events 54 ximelagatran 54 HbA1c levels 54 placebo p = 54 events MACE 54 estimated glomerular filtration 54 heavily pretreated 53 systemic embolism 53 superficial bladder cancer 53 rehospitalization 53 relapsed refractory multiple myeloma